The Effect of Preoperative Maxigesic® on Intraoperative Remifentanil Requirement

Recruiting now · Not applicable

Conditions studied: Opioid Use

In brief

Maxigesic is combined intravenous analgesic of ibuprofen and acetaminphen. The purpose of this study is investigate weather preoperative Maxigesic administration can reduce intraoperative remifentanil requirement.

Key facts

Study ID

NCT06015711

Run by

Ajou University School of Medicine

People needed

96

Starts

2023-08-30

Expected to finish

2026-12-31

Last updated by the study team

2025-10-03

Who can join

Age: 19 and older, up to 60. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Adult patients (19-60 years old) with ASA physical status 1, 2, 3
• Scheduled surgery under general anesthesia

You may not qualify if…

• The patient does not conset
• Pregnancy
• hepatic disorder
• Renal disorder
• Asthma
• Hypersensitivity to the NSAIDs or acetaminophen
• Patients receiving chronic pain therapy
• Drug dependence
• Patients taking psychiatric drugs
• Alcoholics
• History of gastrointestinal ulcer or bleeding

Where it is running

• Ajou university school of medicine — Suwon, Gyeonggi-do, South Korea (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.